Fluticasone Propionate And Salmeterol Powder
Product Images NDC 0527-6010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate And Salmeterol (NDC 0527-6010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fluticasone Propionate Chemical Structure (Fluticasone Propionate And Salmeterol Inhalation P 1)

Fluticasone Propionate Chemical Structure (Fluticasone Propionate And Salmeterol Inhalation P 1)
FDA Label Image

Figure C (Fluticasone Propionate And Salmeterol Inhalation P 10)

Figure C (Fluticasone Propionate And Salmeterol Inhalation P 10)
FDA Label Image

Figure D (Fluticasone Propionate And Salmeterol Inhalation P 11)

Figure D (Fluticasone Propionate And Salmeterol Inhalation P 11)
FDA Label Image

Figure E (Fluticasone Propionate And Salmeterol Inhalation P 12)

Figure E (Fluticasone Propionate And Salmeterol Inhalation P 12)
FDA Label Image

Figure F (Fluticasone Propionate And Salmeterol Inhalation P 13)

Figure F (Fluticasone Propionate And Salmeterol Inhalation P 13)
FDA Label Image

Figure G (Fluticasone Propionate And Salmeterol Inhalation P 14)

Figure G (Fluticasone Propionate And Salmeterol Inhalation P 14)
FDA Label Image

Figure H (Fluticasone Propionate And Salmeterol Inhalation P 15)

Figure H (Fluticasone Propionate And Salmeterol Inhalation P 15)
FDA Label Image

100 Mcg Carton (Fluticasone Propionate And Salmeterol Inhalation P 16)

100 Mcg Carton (Fluticasone Propionate And Salmeterol Inhalation P 16)
This description includes information about a medication with NDC number 0527-6010-06, which is an inhalation powder containing Fluticasone Propionate and Salmeterol. Each blister contains 100 mcg of fluticasone and 72.5 mcg of salmeterol. It is for oral inhalation only and comes in a package with 60 blisters. The medication is contained in an inhalation device named Respirent.*
FDA Label Image

250 Carton (Fluticasone Propionate And Salmeterol Inhalation P 17)

250 Carton (Fluticasone Propionate And Salmeterol Inhalation P 17)
This is a product description for Fluticasone Propionate and Salmeterol Inhalation Powder, USP. It is intended for oral inhalation only and comes in packs of 60 blisters. Each blister contains 250 mcg fluticasone propionate and 72.5 mcg salmeterol xinafoate, equivalent to 50 mcg of salmeterol base, along with lactose. The product includes an inhalation device with 1 foil strip of 60 blisters.*
FDA Label Image

Salmeterol Xinafoate Chemical Structure (Fluticasone Propionate And Salmeterol Inhalation P 2)

Salmeterol Xinafoate Chemical Structure (Fluticasone Propionate And Salmeterol Inhalation P 2)
FDA Label Image

Figure 1 (Fluticasone Propionate And Salmeterol Inhalation P 3)

Figure 1 (Fluticasone Propionate And Salmeterol Inhalation P 3)
This text provides information on the dosage of Fluticasone Propionate and Salmeterol, including quantities to be taken twice daily. The specified amounts are 100 mcg/50 mcg for the combined medication, 100 mcg for Fluticasone propionate alone, and 50 mcg for Salmeterol alone. The data also includes separate values for the placebo group.*
FDA Label Image

Figure 2 (Fluticasone Propionate And Salmeterol Inhalation P 4)

Figure 2 (Fluticasone Propionate And Salmeterol Inhalation P 4)
FDA Label Image

Figure 3 (Fluticasone Propionate And Salmeterol Inhalation P 5)

Figure 3 (Fluticasone Propionate And Salmeterol Inhalation P 5)
FDA Label Image

Figure 4 (Fluticasone Propionate And Salmeterol Inhalation P 6)

Figure 4 (Fluticasone Propionate And Salmeterol Inhalation P 6)
FDA Label Image

Figure 5 (Fluticasone Propionate And Salmeterol Inhalation P 7)

Figure 5 (Fluticasone Propionate And Salmeterol Inhalation P 7)
FDA Label Image

Figure A (Fluticasone Propionate And Salmeterol Inhalation P 8)

Figure A (Fluticasone Propionate And Salmeterol Inhalation P 8)
This is not-available.*
FDA Label Image

Figure B (Fluticasone Propionate And Salmeterol Inhalation P 9)

Figure B (Fluticasone Propionate And Salmeterol Inhalation P 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.